AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025
The forecast has been updated: September 28, 2022 12:52
Allogene Therapeutics stock price online today
Analyst Target Price
27.13Dividend Date
-Ex Dividend Date
-Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2022, 2023, 2024?
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $27.13 target price for Allogene Therapeutics stock stock.
Today 200 Day Moving Average is the resistance level (11.4 $).
50 Day Moving Average is the resistance level (14.19 $).
Allogene Therapeutics stock monthly Forecast
| Date | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| 30 Sep 22 | 11.74 | 11.44 | 12.07 | 5.53 % |
| 01 Oct 22 | 11.60 | 11.27 | 12.24 | 8.65 % |
| 02 Oct 22 | 11.53 | 11.23 | 11.74 | 4.53 % |
| 03 Oct 22 | 10.95 | 10.68 | 11.54 | 8.11 % |
| 04 Oct 22 | 10.90 | 10.74 | 11.22 | 4.48 % |
| 05 Oct 22 | 11.35 | 11.17 | 11.86 | 6.19 % |
| 06 Oct 22 | 11.10 | 10.51 | 11.50 | 9.38 % |
| 07 Oct 22 | 11.11 | 10.54 | 11.62 | 10.25 % |
| 08 Oct 22 | 11.31 | 10.79 | 11.93 | 10.57 % |
| 09 Oct 22 | 11.64 | 11.44 | 11.87 | 3.77 % |
| 10 Oct 22 | 11.31 | 11.04 | 11.83 | 7.25 % |
| 11 Oct 22 | 11.66 | 11.47 | 12.16 | 5.98 % |
| 12 Oct 22 | 11.63 | 11.24 | 12.28 | 9.27 % |
| 13 Oct 22 | 11.60 | 11.20 | 11.83 | 5.65 % |
| 14 Oct 22 | 11.97 | 11.54 | 12.60 | 9.15 % |
| 15 Oct 22 | 11.61 | 11.21 | 11.80 | 5.29 % |
| 16 Oct 22 | 11.74 | 11.43 | 12.15 | 6.25 % |
| 17 Oct 22 | 11.72 | 11.25 | 11.95 | 6.27 % |
| 18 Oct 22 | 11.42 | 11.04 | 11.67 | 5.65 % |
| 19 Oct 22 | 11.64 | 11.19 | 12.23 | 9.25 % |
| 20 Oct 22 | 11.57 | 11.04 | 12.18 | 10.27 % |
| 21 Oct 22 | 11.51 | 11.13 | 11.86 | 6.51 % |
| 22 Oct 22 | 12.12 | 11.68 | 12.40 | 6.10 % |
| 23 Oct 22 | 12.21 | 11.90 | 12.67 | 6.46 % |
| 24 Oct 22 | 11.97 | 11.43 | 12.41 | 8.50 % |
| 25 Oct 22 | 11.64 | 11.38 | 11.91 | 4.65 % |
| 26 Oct 22 | 11.17 | 10.74 | 11.75 | 9.39 % |
| 27 Oct 22 | 11.27 | 10.87 | 11.87 | 9.22 % |
| 28 Oct 22 | 11.50 | 11.28 | 11.81 | 4.71 % |
| 29 Oct 22 | 11.78 | 11.59 | 12.44 | 7.26 % |
ALLO daily forecast for this month
Estimated Average Forecasted Allogene Therapeutics Price: 11.74 Positive intraday dynamics of the instrument is expected with 5.244% volatility is expected.
Pessimistic forecast: 11.44
Optimistic: 12.07
Allogene Therapeutics stock forecast for 01.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.60 Negative intraday dynamics of the instrument is expected with 7.959% volatility is expected.
Pessimistic forecast: 11.27
Optimistic: 12.24
Allogene Therapeutics stock forecast for 02.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.53 Negative intraday dynamics of the instrument is expected with 4.331% volatility is expected.
Pessimistic forecast: 11.23
Optimistic: 11.74
Allogene Therapeutics stock forecast for 03.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 10.95 Negative intraday dynamics of the instrument is expected with 7.505% volatility is expected.
Pessimistic forecast: 10.68
Optimistic: 11.54
Allogene Therapeutics stock forecast for 04.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 10.90 Negative intraday dynamics of the instrument is expected with 4.284% volatility is expected.
Pessimistic forecast: 10.74
Optimistic: 11.22
ALLO Forecast for 2022
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Oct | 10.25 | 10.02 | 10.89 | 8.00 % |
| Nov | 10.56 | 10.34 | 10.89 | 5.04 % |
| Dec | 11.05 | 10.31 | 11.42 | 9.68 % |
Allogene Therapeutics stock forecast for this year
Allogene Therapeutics share price average forecast for Oct 2022 is: 10.2483 The dynamics are negative.
Allogene Therapeutics share price average forecast for Nov 2022 is: 10.5557 The dynamics are positive.
Allogene Therapeutics share price average forecast for Dec 2022 is: 11.0519 The dynamics are positive.
Allogene Therapeutics stock Forecast for 2023
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 10.62 | 10.21 | 11.40 | 10.44 % |
| Feb | 9.71 | 8.95 | 10.35 | 13.51 % |
| Mar | 9.31 | 8.98 | 9.55 | 5.95 % |
| Apr | 9.72 | 9.49 | 10.36 | 8.44 % |
| May | 9.25 | 8.70 | 9.84 | 11.57 % |
| Jun | 8.87 | 8.42 | 9.27 | 9.19 % |
| Jul | 8.13 | 7.76 | 8.62 | 9.99 % |
| Aug | 8.27 | 7.70 | 8.50 | 9.44 % |
| Sep | 8.18 | 7.74 | 8.77 | 11.75 % |
| Oct | 8.20 | 8.00 | 8.69 | 7.92 % |
| Nov | 8.09 | 7.86 | 8.48 | 7.35 % |
| Dec | 7.94 | 7.69 | 8.35 | 7.89 % |
Allogene Therapeutics stock Forecast for 2024
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 7.79 | 7.49 | 8.06 | 7.05 % |
| Feb | 7.67 | 7.39 | 8.25 | 10.50 % |
| Mar | 7.41 | 7.15 | 7.66 | 6.58 % |
| Apr | 7.43 | 7.02 | 7.83 | 10.33 % |
| May | 6.99 | 6.48 | 7.51 | 13.77 % |
| Jun | 6.73 | 6.45 | 7.19 | 10.30 % |
| Jul | 6.82 | 6.48 | 7.34 | 11.70 % |
| Aug | 6.41 | 5.92 | 6.54 | 9.51 % |
| Sep | 6.33 | 6.00 | 6.57 | 8.58 % |
| Oct | 6.69 | 6.48 | 7.09 | 8.50 % |
| Nov | 6.64 | 6.45 | 6.88 | 6.27 % |
| Dec | 6.60 | 6.10 | 6.95 | 12.24 % |
Allogene Therapeutics stock Forecast for 2025
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 6.26 | 5.88 | 6.67 | 11.90 % |
| Feb | 6.17 | 5.79 | 6.37 | 9.01 % |
| Mar | 5.90 | 5.52 | 6.20 | 11.04 % |
| Apr | 5.97 | 5.84 | 6.18 | 5.50 % |
| May | 5.91 | 5.66 | 6.11 | 7.36 % |
| Jun | 5.65 | 5.50 | 5.99 | 8.22 % |
| Jul | 5.56 | 5.40 | 5.81 | 7.07 % |
| Aug | 5.74 | 5.59 | 6.14 | 8.96 % |
| Sep | 6.19 | 6.02 | 6.68 | 9.91 % |
| Oct | 6.43 | 6.16 | 6.67 | 7.71 % |
| Nov | 7.05 | 6.79 | 7.50 | 9.49 % |
| Dec | 7.54 | 7.11 | 7.80 | 8.80 % |
Allogene Therapeutics stock Forecast for 2026
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 7.73 | 7.11 | 8.00 | 11.11 % |
| Feb | 7.16 | 6.78 | 7.55 | 10.15 % |
| Mar | 7.47 | 7.11 | 7.65 | 7.13 % |
| Apr | 7.23 | 6.80 | 7.61 | 10.65 % |
| May | 7.67 | 7.20 | 8.04 | 10.40 % |
| Jun | 8.27 | 7.74 | 8.53 | 9.30 % |
| Jul | 7.97 | 7.53 | 8.38 | 10.17 % |
| Aug | 8.60 | 8.34 | 9.20 | 9.35 % |
| Sep | 9.36 | 8.70 | 9.84 | 11.61 % |
| Oct | 9.02 | 8.79 | 9.38 | 6.25 % |
| Nov | 9.86 | 9.16 | 10.07 | 9.01 % |
| Dec | 9.50 | 8.81 | 9.84 | 10.42 % |
Allogene Therapeutics overview
Allogene Therapeutics Address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, USMarket Capitalization
1 527 230 000 $EBITDA
-294 208 992PE Ratio
NonePEG Ratio
NoneDividend Per Share
0Dividend Yield
0EPS
-2.2Quarterly Earnings Growth YOY
0Quarterly Revenue Growth YOY
0.955Trailing PE
-Forward PE
-EV To Revenue
4595.01EV To EBITDA
-3.85852 Week High
26.2152 Week Low
6.4350 Day Moving Average
14.19200 Day Moving Average
11.4Shares Outstanding
143807000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.